HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 9-22-2023 Insider Buy |
Edwin Rock Chief Medical Officer |
$1.38 CAGR » |
$90,256.14 65,403 shares |
| 5-10-2023 Insider Buy |
Daniel M. Junius Director |
$1.56 CAGR » |
$46,800.00 30,000 shares |
| 2-17-2023 Insider Buy |
Invus Public Equities, L.P. >10% Owner |
$2.00 CAGR » |
$3,027,928.63 1,515,266 shares |
| 2-9-2023 Insider Buy |
Invus Public Equities, L.P. >10% Owner |
$3.24 CAGR » |
$37,123.00 11,451 shares |
| 12-22-2022 Insider Buy |
Edwin Rock Chief Medical Officer |
$2.25 CAGR » |
$247,500.00 110,000 shares |
| 11-11-2022 Insider Buy |
Armand Girard SVP, Chief Business Officer |
$1.05 CAGR » |
$6,825.00 6,500 shares |
| 11-11-2022 Insider Buy |
John L. Magnani SVP of Research, CSO |
$1.17 CAGR » |
$52,702.65 45,045 shares |
| 11-11-2022 Insider Buy |
Brian M. Hahn SVP Finance, CFO |
$1.06 CAGR » |
$21,200.00 20,000 shares |
| 11-11-2022 Insider Buy |
Harout Semerjian Chief Executive Officer |
$1.29 CAGR » |
$32,250.00 25,000 shares |
| 11-4-2020 Insider Buy |
Partners L. P/IL Bvf >10% Owner |
$2.60 CAGR » |
$3,293,516.20 1,266,737 shares |
| 10-30-2020 Insider Buy |
Partners L. P/IL Bvf >10% Owner |
$2.75 CAGR » |
$2,564,683.00 932,612 shares |
| 3-9-2020 Insider Buy |
Daniel M. Junius Director |
$3.40 CAGR » |
$68,000.00 20,000 shares |
| 12-20-2016 Insider Buy |
Daniel M. Junius Director |
$6.01 CAGR » |
$30,050.00 5,000 shares |
| 3-4-2016 Insider Buy |
Mark Alan Goldberg Director |
$4.77 CAGR » |
$49,630.08 10,397 shares |
| 6-13-2014 Insider Buy |
Michael A. Henos Director |
$6.39 CAGR » |
$70,290.00 11,000 shares |
| 1-15-2014 Insider Buy |
Enterprise Associates 10 L. P. New >10% Owner |
$8.00 CAGR » |
$3,900,000.00 487,500 shares |
| 1-15-2014 Insider Buy |
Enterprise Associates 13 LP New >10% Owner |
$8.00 CAGR » |
$4,100,000.00 512,500 shares |
| 1-15-2014 Insider Buy |
M. James Barrett Director and >10% Owner |
$8.00 CAGR » |
$8,000,000.00 1,000,000 shares |
| 1-15-2014 Insider Buy |
Scott D. Sandell >10% Owner |
$8.00 CAGR » |
$8,000,000.00 1,000,000 shares |
| 1-15-2014 Insider Buy |
Peter J. Barris >10% Owner |
$8.00 CAGR » |
$8,000,000.00 1,000,000 shares |
Also See: Institutional Holders of GLYC
Also See: SEC filings
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 09/25/2023 | |
| End date: | 04/26/2024 | |
| Start price/share: | $1.29 | |
| End price/share: | $1.64 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 27.13% | |
| Annualized Gain: | 46.28% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $12,713.00 | |
| Years: | 0.59 | |
GlycoMimetics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent GlycoMimetics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding GLYC
 Free GLYC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the GlycoMimetics Insider Buying occurred are:
DIRTT Environmental Solutions Insider Buying
|
